Mitral valve ring for leaky valve with open heart surgery
Part of Heart & circulation clinical trials.
This trial tests a device placed during open heart surgery that tightens the leaking mitral valve to reduce blood flowing backward. It may help people whose valve leak is caused by heart muscle weakness and who are already having another heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe mitral regurgitation caused by heart muscle disease (ischemic/functional type).
- You are already scheduled for another heart surgery, like a bypass, or are on the heart transplant waiting list.
- You are 22 years or older.
- Your heart pumping strength is at least 25% and your kidney function is not severely reduced.
- You have been on stable, recommended heart failure medications for at least 90 days.
- You have not had prior mitral valve surgery or a valve repair procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device for people whose mitral valve leaks badly (grade 3+ or 4+) and who are not candidates for surgery. The device aims to fix the leak through a less invasive approach, and the study checks if it's safe and works well in daily life.
This trial is testing a new device to help people with severe mitral regurgitation (a leaky heart valve) who cannot have open-heart surgery or a valve clip. The device is placed using a thin tube through a blood vessel, and aims to improve symptoms and quality of life.
This study tests a new device called the MRace implant that is designed to repair a leaky mitral valve without open-heart surgery. It may help people with severe leakage who are at high risk for traditional surgery.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial tests a new device that is placed using a thin tube through a vein in the leg to repair a leaky mitral valve in people with heart failure. The goal is to see if it can reduce symptoms and improve quality of life beyond what usual medications can do.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
Hear when a new Ischemic Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.